The partnership between Asahi Kasei Bioprocess America and PeptiSystems will extend globally across all relevant markets, such as drug- and contract manufacturing. Based on flow-through chemistry and ...

Through the convergent approach, greater efficiency is achieved by utilising common steps to produce multiple ... focusing on oligonucleotide synthesis at ETH Zurich and Roche.

The authors created a useful collection of Rep protein variants with changes that alter the amino acid sequence, but these did not lead to clear improvements in how the virus worked. Instead, their ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Oligo Factory’s new low-scale synthesis capability gives researchers the flexibility to order single oligos or small prototype batches, at volumes as low as 50 nmol with the same speed, service, and ...

Recent technological advances have opened new possibilities for the efficient and sustainable synthesis of various valuable ...

The technical aspects involved with the design, synthesis and use of oligonucleotide arrays for gene expression experiments are now fairly routine. New breakthroughs will require careful ...

This valuable study investigates how stochastic and deterministic factors are integrated during cellular decision-making, particularly in situations where cells differentiate into distinct fates ...

oligonucleotide and peptide synthesis (ONS) chemicals in the United States and Canada for pharmaceutical and biopharmaceutical applications. As the pharmaceutical industry continues to evolve ...

From bench to bulk, pharmaceutical customers will benefit from the latest solvent innovations and technologies in addition to an expanded portfolio with the Tedia partnership "We are very excited ...